NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

子宮頸癌症診斷的全球市場:類型(子宮頸部切片檢查,陰道鏡檢查,膀胱鏡檢驗,HPV檢驗,子宮頸抹片篩檢) - 至2025年的預測,COVID-19累積的影響

Cervical Cancer Diagnostic Market Research Report by Type, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 973221
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
子宮頸癌症診斷的全球市場:類型(子宮頸部切片檢查,陰道鏡檢查,膀胱鏡檢驗,HPV檢驗,子宮頸抹片篩檢) - 至2025年的預測,COVID-19累積的影響 Cervical Cancer Diagnostic Market Research Report by Type, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 180 Pages
簡介

全球子宮頸癌症診斷的市場規模,是2019年168億5,371萬美金。該市場,預計至2025年期間以7.13%的年複合成長率成長,2025年達到254億8,138萬美元。

本報告提供全球子宮頸癌症診斷市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19的影響,各類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 調查手法

  • 調查流程
  • 調查的實行
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 類型預測
  • 地區預測
  • 競爭預測

第4章 市場概要

  • 簡介

第5章 市場動態

  • 簡介
  • 成長要素
    • 人們的意識及技術進步
    • 醫療保健基礎設施的改善和子宮頸癌症的盛行率增加
  • 阻礙因素
    • 人類乳突病毒(HPV)疫苗接種的增加
    • 新興各國缺乏意識
  • 市場機會
    • 各政府及非官方機構的積極舉措
  • 課題
    • 子宮頸癌症診斷的成本高

第6章 市場洞察

  • 波特的五力分析
  • COVID-19累積的影響
  • 客戶的客製化

第7章 市場分析:各類型

  • 簡介
  • 子宮頸部切片檢查
  • 陰道鏡檢查
  • 膀胱鏡檢驗
  • HPV檢驗
  • 子宮頸抹片篩檢

第8章 南北美洲市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV Positioning Matrix
  • 市場排行榜分析
  • 市場佔有率分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及聯盟
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獲獎,獎勵,擴大

第12章 企業簡介

  • Abbott Laboratories
  • Advaxis Inc.
  • Arbor Vita
  • Arbor Vita Corporation
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Bristol-Myers Squibb Company
  • Cardinal Health
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline PLC
  • Guided Therapeutics
  • Hologic, Inc.
  • Merck & Co. Inc.
  • Qiagen NV
  • Quest Diagnostics, Inc.
  • Siemens Healthcare
  • Zilico Ltd.

第13章 附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-4756B70362FC

The Global Cervical Cancer Diagnostic Market size was estimated at USD 15.25 Billion in 2020 and expected to reach USD 16.70 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 9.84% to reach USD 26.80 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cervical Cancer Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type , the Cervical Cancer Diagnostic Market was studied across Cervical Biopsies, Colposcopy, Cystoscopy, HPV Testing, and Pap testing.

Based on End-User, the Cervical Cancer Diagnostic Market was studied across Cancer and Radiation therapy Centers, Hospital, and Speciality Clinics & Diagnostic Centers.

Based on Geography, the Cervical Cancer Diagnostic Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cervical Cancer Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cervical Cancer Diagnostic Market, including Abbott Laboratories, Advaxis Inc., Arbor Vita Corporation, Beckman Coulter Inc., Becton, Dickinson and Company, Bristol-Myers Squibb Company, Cardinal Health, Coopersurgical Inc, Dr Lal PathLabs, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Guided Therapeutics, Hologic, Inc., Merck & Co. Inc., OncoHealth Corp, Pan American Health Organization, Qiagen NV, Quest Diagnostics, Inc., Siemens Healthcare, and Zilico Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cervical Cancer Diagnostic Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cervical Cancer Diagnostic Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cervical Cancer Diagnostic Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cervical Cancer Diagnostic Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cervical Cancer Diagnostic Market?
  • 6. What is the market share of the leading vendors in the Global Cervical Cancer Diagnostic Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cervical Cancer Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Awareness among people and technological advancements
      • 5.1.1.2. Improvement in healthcare infrastructure and increased prevalence of cervical cancer
    • 5.1.2. Restraints
      • 5.1.2.1. Increased use of HPV vaccination
      • 5.1.2.2. Lack of awareness in developing countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Proactive initiatives by various government and non-government organizations
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of cervical cancer diagnostics procedures
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Cervical Cancer Diagnostic Market, by Type

  • 6.1. Introduction
  • 6.2. Cervical Biopsies
  • 6.3. Colposcopy
  • 6.4. Cystoscopy
  • 6.5. HPV Testing
  • 6.6. Pap testing

7. Cervical Cancer Diagnostic Market, by End-User

  • 7.1. Introduction
  • 7.2. Cancer and Radiation therapy Centers
  • 7.3. Hospital
  • 7.4. Speciality Clinics & Diagnostic Centers

8. Americas Cervical Cancer Diagnostic Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Cervical Cancer Diagnostic Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Cervical Cancer Diagnostic Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Advaxis Inc.
  • 12.3. Arbor Vita Corporation
  • 12.4. Beckman Coulter Inc.
  • 12.5. Becton, Dickinson and Company
  • 12.6. Bristol-Myers Squibb Company
  • 12.7. Cardinal Health
  • 12.8. Coopersurgical Inc
  • 12.9. Dr Lal PathLabs
  • 12.10. F. Hoffmann-La Roche Ltd
  • 12.11. GlaxoSmithKline PLC
  • 12.12. Guided Therapeutics
  • 12.13. Hologic, Inc.
  • 12.14. Merck & Co. Inc.
  • 12.15. OncoHealth Corp
  • 12.16. Pan American Health Organization
  • 12.17. Qiagen NV
  • 12.18. Quest Diagnostics, Inc.
  • 12.19. Siemens Healthcare
  • 12.20. Zilico Ltd.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2020 (USD BILLION)
  • FIGURE 4. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2026
  • FIGURE 10. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CERVICAL BIOPSIES, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CERVICAL BIOPSIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COLPOSCOPY, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COLPOSCOPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CYSTOSCOPY, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CYSTOSCOPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HPV TESTING, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HPV TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY PAP TESTING, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY PAP TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2026
  • FIGURE 23. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CANCER AND RADIATION THERAPY CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CANCER AND RADIATION THERAPY CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY SPECIALITY CLINICS & DIAGNOSTIC CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY SPECIALITY CLINICS & DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 33. BRAZIL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 34. CANADA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 35. MEXICO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 36. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 37. CALIFORNIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 38. FLORIDA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. ILLINOIS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. NEW YORK CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. OHIO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. PENNSYLVANIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. TEXAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. INDIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. INDONESIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. JAPAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. MALAYSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. PHILIPPINES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. SOUTH KOREA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. THAILAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. GERMANY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. ITALY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. NETHERLANDS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. QATAR CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. RUSSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. SAUDI ARABIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. SOUTH AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. SPAIN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. UNITED ARAB EMIRATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. UNITED KINGDOM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CERVICAL BIOPSIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COLPOSCOPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CYSTOSCOPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HPV TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY PAP TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CANCER AND RADIATION THERAPY CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY SPECIALITY CLINICS & DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. ARGENTINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. ARGENTINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. BRAZIL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. BRAZIL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. CANADA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. CANADA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. MEXICO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. MEXICO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CALIFORNIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. CALIFORNIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. FLORIDA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. FLORIDA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. ILLINOIS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. ILLINOIS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. NEW YORK CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. NEW YORK CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. OHIO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. OHIO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. PENNSYLVANIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. PENNSYLVANIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. TEXAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. TEXAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. CHINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. CHINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. INDIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. INDIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. INDONESIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. INDONESIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. JAPAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. JAPAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. MALAYSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. MALAYSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. PHILIPPINES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. PHILIPPINES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. SOUTH KOREA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. SOUTH KOREA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. THAILAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. THAILAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. FRANCE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. FRANCE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. GERMANY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. GERMANY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. ITALY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. ITALY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. NETHERLANDS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. NETHERLANDS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. QATAR CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. QATAR CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. RUSSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. RUSSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. SAUDI ARABIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. SAUDI ARABIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. SOUTH AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SOUTH AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SPAIN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SPAIN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. UNITED ARAB EMIRATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. UNITED ARAB EMIRATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. UNITED KINGDOM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. UNITED KINGDOM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: SCORES
  • TABLE 86. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: BUSINESS STRATEGY
  • TABLE 87. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: PRODUCT SATISFACTION
  • TABLE 88. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: RANKING
  • TABLE 89. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 90. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • TABLE 91. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: MERGER & ACQUISITION
  • TABLE 92. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 93. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 94. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: INVESTMENT & FUNDING
  • TABLE 95. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 96. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: LICENSE & PRICING
  • TABLE 97. GLOBAL CERVICAL CANCER DIAGNOSTIC MARKET: CONTACT DETAILS